Lanean...
An Update on SGLT2 Inhibitors for the Treatment of Diabetes Mellitus
PURPOSE OF REVIEW: SGLT2 inhibitors are the newest class of oral anti-hyperglycemic agents that have been approved for the treatment of diabetes mellitus. Over the past year there have been significant developments in both the safety and efficacy of this class of medications that are presented in th...
Gorde:
| Argitaratua izan da: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6028052/ https://ncbi.nlm.nih.gov/pubmed/27898586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000311 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|